PRECISIS GmbH

PRECISIS GmbH is a medical technology company based in Heidelberg, Germany, founded in 2004.

The company specializes in minimally invasive bioelectronic therapies and neuromodulation for neurological disorders. Its flagship product, EASEE®, is the first CE-certified, low-invasive neurostimulation system designed for drug-resistant focal epilepsy. This innovative device uses epicranial electrodes implanted beneath the scalp to deliver therapeutic currents to specific brain areas, significantly reducing surgical risks and recovery times. PRECISIS aims to improve the lives of individuals with functional brain diseases by developing targeted therapies. The company has received recognition for its work, including the Innovation Award of Baden-Württemberg in 2023 and a spot in the TOP 100 Innovators list. With a focus on expanding its technology platform, PRECISIS is also exploring applications for other conditions such as depression, Parkinson’s disease, chronic pain, and cognitive impairments. The company is committed to providing patient-centered solutions for those who have not found success with traditional treatments.